Key result
Loss of PTPRZ1 in mouse and zebrafish models resulted in dilated left ventricle cavity, decreased ejection fraction, and fraction shortening, indicating a role in heart development.
Why the study?
PTPRZ1 is expressed in fetal but not adult heart and appears to affect heart development, with its role in congenital cardiac pathologies unclear.
PTPRZ1 deletion in animal models causes defective heart morphogenesis, suggesting a potential role in congenital cardiac pathologies.
1 (PTPRZ1) is expressed in fetal but not adult heart and seems to affect heart development. In both mouse and zebrafish animal models, loss of PTPRZ1 results in dilated left ventricle cavity, decreased ejection fraction, and fraction shortening, with no signs of cardiac hypertrophy. PTPRZ1 also seems to be involved in atrioventricular canal specification, outflow tract morphogenesis, and heart angiogenesis. These results suggest that PTPRZ1 plays a role in heart development and support the hypothesis that it may be involved in congenital cardiac pathologies.
No takes yet. Share an insight, caveat, or question.
Katraki-Pavlou et al. (2021) studied Heart development. PTPRZ1 deletion was evaluated on Heart morphogenesis (left ventricle cavity size, ejection fraction, fraction shortening). Loss of PTPRZ1 in mouse and zebrafish models resulted in dilated left ventricle cavity, decreased ejection fraction, and fraction shortening, indicating a role in heart development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: